| 1 |
Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.Oncol Rep. 2019 Mar;41(3):1960-1970. doi: 10.3892/or.2018.6923. Epub 2018 Dec 10.
|
| 2 |
Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.Ann Oncol. 2008 Mar;19(3):527-32. doi: 10.1093/annonc/mdm469. Epub 2007 Oct 26.
|
| 3 |
A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.Oncotarget. 2016 May 24;7(21):31137-52. doi: 10.18632/oncotarget.9082.
|
| 4 |
Grim-19 expressed by recombinant adenovirus for esophageal neoplasm target therapy.Mol Med Rep. 2018 May;17(5):6667-6674. doi: 10.3892/mmr.2018.8638. Epub 2018 Feb 27.
|
| 5 |
Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers.Hum Pathol. 2018 May;75:116-124. doi: 10.1016/j.humpath.2018.02.008. Epub 2018 Feb 13.
|
| 6 |
B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu).Mutat Res. 1993 Oct;289(2):187-95. doi: 10.1016/0027-5107(93)90069-r.
|
| 7 |
Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.Anticancer Res. 1998 May-Jun;18(3A):1465-72.
|
| 8 |
Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.PLoS One. 2013 Dec 13;8(12):e82790. doi: 10.1371/journal.pone.0082790. eCollection 2013.
|
| 9 |
PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.Ann Surg. 2019 Mar;269(3):471-478. doi: 10.1097/SLA.0000000000002616.
|
| 10 |
The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.World J Surg. 2018 Mar;42(3):749-757. doi: 10.1007/s00268-017-4203-4.
|
| 11 |
Malignant progression in O6-methylguanine-DNA methyltransferase-deficient esophageal cancer cells is associated with Ezrin protein.DNA Cell Biol. 2012 May;31(5):856-66. doi: 10.1089/dna.2011.1318. Epub 2011 Dec 23.
|
| 12 |
Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.Eur J Cancer. 2006 May;42(7):972-80. doi: 10.1016/j.ejca.2006.01.021. Epub 2006 Mar 27.
|
| 13 |
PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.World J Surg Oncol. 2017 May 25;15(1):105. doi: 10.1186/s12957-017-1172-x.
|
| 14 |
Clinical significance of the expression of activin A in esophageal carcinoma.Int J Oncol. 2003 Jan;22(1):75-80.
|
| 15 |
Regulation of OLC1 protein expression by the anaphase-promoting complex.Oncol Lett. 2019 Mar;17(3):2639-2646. doi: 10.3892/ol.2019.9881. Epub 2019 Jan 2.
|
| 16 |
MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.Cancer. 2001 May 15;91(10):1882-8.
|
| 17 |
Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo.Oncol Lett. 2019 Jun;17(6):5012-5022. doi: 10.3892/ol.2019.10160. Epub 2019 Mar 19.
|
| 18 |
Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma.Int J Cancer. 1999 Sep 24;83(1):38-44. doi: 10.1002/(sici)1097-0215(19990924)83:1<38::aid-ijc8>3.0.co;2-b.
|
| 19 |
Dual effects of an anti-CD147 antibody for Esophageal cancer therapy.Cancer Biol Ther. 2019;20(12):1443-1452. doi: 10.1080/15384047.2019.1647052. Epub 2019 Aug 14.
|
| 20 |
The prognostic significance of high/positive expression of cyclin B1 in patients with three common digestive cancers: a systematic review and meta-analysis.Oncotarget. 2017 Sep 26;8(56):96373-96383. doi: 10.18632/oncotarget.21273. eCollection 2017 Nov 10.
|
| 21 |
Correlation between the protein expression levels of A-kinase anchor protein95, p-retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues.Asia Pac J Clin Oncol. 2019 Oct;15(5):e162-e166. doi: 10.1111/ajco.13146. Epub 2019 Apr 16.
|
| 22 |
Expression of immune checkpoints in T cells of esophageal cancer patients.Oncotarget. 2016 Sep 27;7(39):63669-63678. doi: 10.18632/oncotarget.11611.
|
| 23 |
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.Oncotarget. 2018 May 4;9(34):23482-23493. doi: 10.18632/oncotarget.25235. eCollection 2018 May 4.
|
| 24 |
Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.Clin Cancer Res. 2016 Mar 1;22(5):1243-55. doi: 10.1158/1078-0432.CCR-15-1196. Epub 2015 Oct 16.
|
| 25 |
Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo.Mol Med Rep. 2015 Jul;12(1):1465-72. doi: 10.3892/mmr.2015.3517. Epub 2015 Mar 20.
|
| 26 |
Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis.Surg Oncol. 2017 Dec;26(4):460-472. doi: 10.1016/j.suronc.2017.09.003. Epub 2017 Sep 14.
|
| 27 |
Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.Mol Carcinog. 2020 Jan;59(1):32-44. doi: 10.1002/mc.23126. Epub 2019 Oct 16.
|
| 28 |
DpdtbA-Induced Growth Inhibition in Human Esophageal Cancer Cells Involved Inactivation of the p53/EGFR/AKT Pathway.Oxid Med Cell Longev. 2019 Jul 1;2019:5414670. doi: 10.1155/2019/5414670. eCollection 2019.
|
| 29 |
CHST15 promotes the proliferation of TE? cells via multiple pathways in esophageal cancer.Oncol Rep. 2020 Jan;43(1):75-86. doi: 10.3892/or.2019.7395. Epub 2019 Oct 30.
|
| 30 |
VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.Cytokine. 2011 Jul;55(1):8-17. doi: 10.1016/j.cyto.2011.03.008. Epub 2011 Apr 11.
|
| 31 |
Variants in COL6A3 gene influence susceptibility to esophageal cancer in the Chinese population.Cancer Genet. 2019 Oct;238:23-30. doi: 10.1016/j.cancergen.2019.07.003. Epub 2019 Jul 13.
|
| 32 |
Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.Kaohsiung J Med Sci. 2020 Jan;36(1):54-61. doi: 10.1002/kjm2.12129. Epub 2019 Sep 12.
|
| 33 |
Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis.Ther Adv Med Oncol. 2017 Jan;9(1):13-21. doi: 10.1177/1758834016668682. Epub 2016 Sep 18.
|
| 34 |
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.Int J Cancer. 2006 Jan 1;118(1):123-8. doi: 10.1002/ijc.21219.
|
| 35 |
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16.
|
| 36 |
Cullin7 promotes epithelialmesenchymal transition of esophageal carcinoma via the ERKSNAI2 signaling pathway.Mol Med Rep. 2018 Apr;17(4):5362-5367. doi: 10.3892/mmr.2018.8503. Epub 2018 Jan 26.
|
| 37 |
Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a high-incidence area of northern China.Oncol Lett. 2019 Aug;18(2):1267-1277. doi: 10.3892/ol.2019.10455. Epub 2019 Jun 7.
|
| 38 |
Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study.BMC Gastroenterol. 2016 Jul 30;16(1):85. doi: 10.1186/s12876-016-0499-z.
|
| 39 |
Translational research on Barrett's esophagus.Ann N Y Acad Sci. 2014 Sep;1325:170-86. doi: 10.1111/nyas.12531.
|
| 40 |
Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.Oncol Res. 2017 Jul 5;25(6):887-895. doi: 10.3727/096504016X14817158982636. Epub 2016 Dec 15.
|
| 41 |
Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma.Cancer. 2002 Dec 15;95(12):2473-8. doi: 10.1002/cncr.10987.
|
| 42 |
Indomethacin induces apoptosis in the EC109 esophageal cancer cell line by releasing second mitochondria-derived activator of caspase and activating caspase-3.Mol Med Rep. 2015 Jun;11(6):4694-700. doi: 10.3892/mmr.2015.3331. Epub 2015 Feb 11.
|
| 43 |
Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.FASEB J. 2019 Feb;33(2):1972-1988. doi: 10.1096/fj.201800759R. Epub 2018 Sep 18.
|
| 44 |
Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma.Acta Histochem. 2014 Jun;116(5):803-9. doi: 10.1016/j.acthis.2014.01.010. Epub 2014 Mar 12.
|
| 45 |
Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.Cell Mol Life Sci. 2019 Dec;76(24):5027-5039. doi: 10.1007/s00018-019-03159-5. Epub 2019 Jun 12.
|
| 46 |
DNA aneuploidy assessment of the effectiveness of hyperthermo-chemo-radiotherapy for esophageal carcinoma.Cancer. 1989 May 15;63(10):1951-5. doi: 10.1002/1097-0142(19890515)63:10<1951::aid-cncr2820631014>3.0.co;2-4.
|
| 47 |
Circular RNA hsa_circ_0030018 acts as a sponge of miR-599 to aggravate esophageal carcinoma progression by regulating ENAH expression.J Cell Biochem. 2020 Aug;121(8-9):3730-3738. doi: 10.1002/jcb.29507. Epub 2019 Nov 17.
|
| 48 |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.
|
| 49 |
Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.Cell Oncol (Dordr). 2018 Dec;41(6):651-662. doi: 10.1007/s13402-018-0399-z. Epub 2018 Aug 16.
|
| 50 |
WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.J Exp Clin Cancer Res. 2019 Feb 26;38(1):102. doi: 10.1186/s13046-019-1108-0.
|
| 51 |
Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.Int J Cancer. 2018 Feb 15;142(4):833-843. doi: 10.1002/ijc.31108. Epub 2017 Nov 30.
|
| 52 |
The expression of protease-activated receptors in esophageal carcinoma cells: the relationship between changes in gene expression and cell proliferation, apoptosis in vitro and growing ability in vivo.Cancer Cell Int. 2018 Jun 7;18:81. doi: 10.1186/s12935-018-0577-0. eCollection 2018.
|
| 53 |
Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.J Surg Oncol. 2018 Jul;118(1):101-108. doi: 10.1002/jso.25127. Epub 2018 Aug 11.
|
| 54 |
Gproteincoupled receptor120 regulates the development and progression of human esophageal cancer.Oncol Rep. 2018 Aug;40(2):1147-1155. doi: 10.3892/or.2018.6470. Epub 2018 May 31.
|
| 55 |
High amplification of the hst-1 gene correlates with haematogenous recurrence after curative resection of oesophageal carcinoma.Br J Surg. 1995 Mar;82(3):364-7. doi: 10.1002/bjs.1800820327.
|
| 56 |
FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.Ann Surg Oncol. 2011 Feb;18(2):535-42. doi: 10.1245/s10434-010-1274-y. Epub 2010 Aug 28.
|
| 57 |
FOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expression.Cell Death Dis. 2017 Jul 20;8(7):e2946. doi: 10.1038/cddis.2017.340.
|
| 58 |
Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias.Pathol Res Pract. 2018 Feb;214(2):181-186. doi: 10.1016/j.prp.2017.12.003. Epub 2017 Dec 7.
|
| 59 |
Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1.Mol Oncol. 2019 Dec;13(12):2554-2573. doi: 10.1002/1878-0261.12555. Epub 2019 Sep 8.
|
| 60 |
Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/-catenin and PI3K/AKT signaling pathways.J Cell Physiol. 2019 Nov;234(11):20469-20484. doi: 10.1002/jcp.28648. Epub 2019 Apr 15.
|
| 61 |
Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.Clin Exp Metastasis. 2013 Dec;30(8):977-92. doi: 10.1007/s10585-013-9597-2. Epub 2013 Jun 21.
|
| 62 |
Upregulation of AUF1 is involved in the proliferation of esophageal squamous cell carcinoma through GCH1.Int J Oncol. 2016 Nov;49(5):2001-2010. doi: 10.3892/ijo.2016.3713. Epub 2016 Sep 28.
|
| 63 |
Cyclopamine Suppresses Human Esophageal Carcinoma Cell Growth by Inhibiting Glioma-Associated Oncogene Protein-1, a Marker of Human Esophageal Carcinoma Progression.Med Sci Monit. 2019 Feb 26;25:1518-1525. doi: 10.12659/MSM.912858.
|
| 64 |
Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.BMC Cancer. 2011 Feb 25;11:86. doi: 10.1186/1471-2407-11-86.
|
| 65 |
Expression and significance of GRHL2 in esophageal cancer.Onco Targets Ther. 2017 Apr 7;10:2025-2031. doi: 10.2147/OTT.S128294. eCollection 2017.
|
| 66 |
Association between glutathione S-transferases P1 Ile105Val polymorphism and susceptibility to esophageal cancer: evidence from 20 case-control studies.Mol Biol Rep. 2015 Feb;42(2):399-408. doi: 10.1007/s11033-014-3781-6. Epub 2014 Oct 4.
|
| 67 |
HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.Cancer Res. 2009 Jun 15;69(12):4969-73. doi: 10.1158/0008-5472.CAN-08-4546. Epub 2009 Jun 2.
|
| 68 |
Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.Clin Cancer Res. 2005 Nov 15;11(22):7995-8005. doi: 10.1158/1078-0432.CCR-05-1103.
|
| 69 |
TGF-1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.Oncotarget. 2015 Feb 10;6(4):2120-33. doi: 10.18632/oncotarget.2940.
|
| 70 |
Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.Cancer Sci. 2019 Jun;110(6):1863-1871. doi: 10.1111/cas.14028. Epub 2019 May 20.
|
| 71 |
Interleukin 10 rs1800872 T>G polymorphism was associated with an increased risk of esophageal cancer in a Chinese population.Asian Pac J Cancer Prev. 2013;14(6):3443-7. doi: 10.7314/apjcp.2013.14.6.3443.
|
| 72 |
IL-15 receptor alpha rs2228059 A>C polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.Mol Biol Rep. 2014;41(4):1951-7. doi: 10.1007/s11033-014-3042-8. Epub 2014 Jan 28.
|
| 73 |
Common Polymorphisms in IL-27 Genes May Contribute to Risk of Various Human Diseases in Asian Populations: A Meta-Analysis.Med Sci Monit. 2016 Mar 7;22:766-75. doi: 10.12659/msm.895558.
|
| 74 |
IL1R2 Polymorphisms are Associated with Increased Risk of Esophageal Cancer.Curr Mol Med. 2020;20(5):379-387. doi: 10.2174/1566524019666191025091204.
|
| 75 |
Rs1884444 variant in IL23R gene is associated with a decreased risk in esophageal cancer in Chinese population.Mol Carcinog. 2019 Oct;58(10):1822-1831. doi: 10.1002/mc.23069. Epub 2019 Jun 13.
|
| 76 |
Integrin 6 promotes esophageal cancer metastasis and is targeted by miR-92b.Oncotarget. 2017 Jan 24;8(4):6681-6690. doi: 10.18632/oncotarget.14259.
|
| 77 |
Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.Am J Cancer Res. 2017 Jan 1;7(1):115-124. eCollection 2017.
|
| 78 |
Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.Int J Cancer. 2019 Feb 15;144(4):828-840. doi: 10.1002/ijc.31953. Epub 2018 Dec 3.
|
| 79 |
Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.J Exp Clin Cancer Res. 2017 Nov 16;36(1):161. doi: 10.1186/s13046-017-0622-1.
|
| 80 |
Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis.Oncol Lett. 2018 Jan;15(1):1229-1235. doi: 10.3892/ol.2017.7433. Epub 2017 Nov 16.
|
| 81 |
LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.Cancer Res. 2019 Oct 1;79(19):4951-4964. doi: 10.1158/0008-5472.CAN-19-0860. Epub 2019 Aug 13.
|
| 82 |
Identification of a novel CD8+ T cell epitope derived from cancer-testis antigen MAGE-4 in oesophageal carcinoma.Scand J Immunol. 2011 Dec;74(6):561-7. doi: 10.1111/j.1365-3083.2011.02606.x.
|
| 83 |
Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues.Exp Ther Med. 2019 Sep;18(3):1816-1822. doi: 10.3892/etm.2019.7735. Epub 2019 Jul 5.
|
| 84 |
Polymorphic variation of the ARP gene on 3p21 in Japanese esophageal cancer patients.Oncol Rep. 2000 May-Jun;7(3):591-3. doi: 10.3892/or.7.3.591.
|
| 85 |
Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).Oncotarget. 2016 Feb 23;7(8):8756-70. doi: 10.18632/oncotarget.6752.
|
| 86 |
Prognostic significance of TPX2 and NIBP in esophageal cancer.Oncol Lett. 2019 Oct;18(4):4221-4229. doi: 10.3892/ol.2019.10747. Epub 2019 Aug 16.
|
| 87 |
Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.BMC Cancer. 2015 Jun 4;15:454. doi: 10.1186/s12885-015-1455-y.
|
| 88 |
MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas.J Cancer. 2018 Jan 1;9(3):460-468. doi: 10.7150/jca.22310. eCollection 2018.
|
| 89 |
MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.Oncol Rep. 2017 Jun;37(6):3590-3596. doi: 10.3892/or.2017.5614. Epub 2017 May 2.
|
| 90 |
MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.J Gene Med. 2019 May;21(5):e3086. doi: 10.1002/jgm.3086. Epub 2019 Apr 8.
|
| 91 |
Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.Cancer Sci. 2018 Nov;109(11):3393-3402. doi: 10.1111/cas.13785. Epub 2018 Sep 22.
|
| 92 |
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.Acta Biochim Pol. 2017;64(2):295-299. doi: 10.18388/abp.2016_1408. Epub 2017 May 15.
|
| 93 |
Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis.PLoS One. 2017 Jun 1;12(6):e0176431. doi: 10.1371/journal.pone.0176431. eCollection 2017.
|
| 94 |
Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients.Cancer Cell Int. 2019 Apr 23;19:106. doi: 10.1186/s12935-019-0824-z. eCollection 2019.
|
| 95 |
Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized Therapy.J Nucl Med. 2017 Feb;58(2):266-275. doi: 10.2967/jnumed.116.176313. Epub 2016 Sep 15.
|
| 96 |
"NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".Nutr Cancer. 2018 May-Jun;70(4):557-568. doi: 10.1080/01635581.2018.1460674. Epub 2018 Apr 13.
|
| 97 |
Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.FASEB J. 2018 Jan;32(1):404-416. doi: 10.1096/fj.201700227RRR. Epub 2017 Sep 19.
|
| 98 |
Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer.J Immunol Res. 2019 Mar 3;2019:6587570. doi: 10.1155/2019/6587570. eCollection 2019.
|
| 99 |
MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.Oncotarget. 2018 Jun 19;9(47):28391-28407. doi: 10.18632/oncotarget.25375. eCollection 2018 Jun 19.
|
| 100 |
CircRAD23B facilitates proliferation and invasion of esophageal cancer cells by sponging miR-5095.Biochem Biophys Res Commun. 2019 Aug 20;516(2):357-364. doi: 10.1016/j.bbrc.2019.06.044. Epub 2019 Jun 14.
|
| 101 |
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.Int J Mol Sci. 2018 Dec 20;20(1):13. doi: 10.3390/ijms20010013.
|
| 102 |
Long non-coding RNA FAL1 regulated cell proliferation through Akt pathway via targeting PDK1 in esophageal cancer cells.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5214-5222. doi: 10.26355/eurrev_201808_15719.
|
| 103 |
Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.Oncol Rep. 2007 Apr;17(4):753-60.
|
| 104 |
Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.Oncol Rep. 2013 Jul;30(1):304-12. doi: 10.3892/or.2013.2464. Epub 2013 May 14.
|
| 105 |
Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma.Asian Pac J Cancer Prev. 2015;16(3):997-1000. doi: 10.7314/apjcp.2015.16.3.997.
|
| 106 |
The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4'-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth.Cancer Prev Res (Phila). 2017 May;10(5):308-318. doi: 10.1158/1940-6207.CAPR-16-0318. Epub 2017 Mar 21.
|
| 107 |
Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.Oncol Rep. 2013 Oct;30(4):1823-31. doi: 10.3892/or.2013.2649. Epub 2013 Aug 1.
|
| 108 |
G648C variant of DNA polymerase sensitizes esophageal cancer to chemotherapy.Tumour Biol. 2016 Feb;37(2):1941-7. doi: 10.1007/s13277-015-3978-x. Epub 2015 Sep 3.
|
| 109 |
Inhibition of atypical protein kinase C induces apoptosis through autophagic degradation of -catenin in esophageal cancer cells.Mol Carcinog. 2014 Jul;53(7):514-25. doi: 10.1002/mc.22003. Epub 2013 Jan 28.
|
| 110 |
Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2014;15(23):10299-306. doi: 10.7314/apjcp.2014.15.23.10299.
|
| 111 |
LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.Mol Biol Rep. 2013 Mar;40(3):2069-75. doi: 10.1007/s11033-012-2138-2. Epub 2013 Jan 3.
|
| 112 |
Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer.Cancer Biol Ther. 2010 Jan;9(2):88-95. doi: 10.4161/cbt.9.2.10283. Epub 2010 Jan 9.
|
| 113 |
F-box protein complex FBXL19 regulates TGF1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation.Mol Cancer. 2014 Apr 1;13:76. doi: 10.1186/1476-4598-13-76.
|
| 114 |
DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.Ann Surg Oncol. 2020 Jun;27(6):2090-2101. doi: 10.1245/s10434-019-08043-x. Epub 2019 Nov 20.
|
| 115 |
Epac1, PDE4, and PKC protein expression and their correlation with AKAP95 and Cx43 in esophagus cancer tissues.Thorac Cancer. 2017 Nov;8(6):572-576. doi: 10.1111/1759-7714.12479. Epub 2017 Aug 3.
|
| 116 |
Retinoic Acid Receptor Knockdown Suppresses the Tumorigenicity of Esophageal Carcinoma via Wnt/-catenin Pathway.Dig Dis Sci. 2018 Dec;63(12):3348-3358. doi: 10.1007/s10620-018-5254-6. Epub 2018 Aug 28.
|
| 117 |
Methylation and expression of RECK, P53 and RUNX genes in patients with esophageal cancer.Oncol Lett. 2017 Nov;14(5):5293-5298. doi: 10.3892/ol.2017.6863. Epub 2017 Aug 31.
|
| 118 |
RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet. 2012 Feb 10;90(2):340-6. doi: 10.1016/j.ajhg.2011.12.008. Epub 2012 Jan 19.
|
| 119 |
lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR?45/p70S6K1 and p53 pathway.Int J Oncol. 2020 Jan;56(1):327-336. doi: 10.3892/ijo.2019.4929. Epub 2019 Dec 2.
|
| 120 |
S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.World J Gastroenterol. 2012 Mar 7;18(9):915-22. doi: 10.3748/wjg.v18.i9.915.
|
| 121 |
SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.Oncotarget. 2017 Mar 14;8(11):17771-17784. doi: 10.18632/oncotarget.14849.
|
| 122 |
Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.Cancer Sci. 2019 May;110(5):1552-1563. doi: 10.1111/cas.13986. Epub 2019 Apr 15.
|
| 123 |
SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.Cell Physiol Biochem. 2018;48(1):397. doi: 10.1159/000491769. Epub 2018 Aug 2.
|
| 124 |
Long-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cells. Dig Dis Sci. 2013 Mar;58(3):694-8.
|
| 125 |
Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That RegulateMetastasis.Gastroenterology. 2017 Jun;152(8):1985-1997.e12. doi: 10.1053/j.gastro.2017.02.006. Epub 2017 Feb 14.
|
| 126 |
Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.Cancer Sci. 2016 Oct;107(10):1499-1505. doi: 10.1111/cas.13021. Epub 2016 Oct 3.
|
| 127 |
Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.Tumour Biol. 2014 Dec;35(12):11871-7. doi: 10.1007/s13277-014-2429-4. Epub 2014 Aug 21.
|
| 128 |
CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.Med Oncol. 2011 Mar;28(1):182-7. doi: 10.1007/s12032-010-9455-x. Epub 2010 Mar 2.
|
| 129 |
LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells.Int J Biochem Cell Biol. 2019 Dec;117:105626. doi: 10.1016/j.biocel.2019.105626. Epub 2019 Oct 9.
|
| 130 |
STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.Ann Surg Oncol. 2011 Jan;18(1):261-72. doi: 10.1245/s10434-010-1271-1. Epub 2010 Aug 24.
|
| 131 |
Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/-catenin signal pathway in colorectal cancer and predicts poor prognosis.Pathol Res Pract. 2019 Jan;215(1):57-67. doi: 10.1016/j.prp.2018.10.018. Epub 2018 Oct 24.
|
| 132 |
Comparative proteome analysis of human esophageal cancer and adjacent normal tissues.Iran J Basic Med Sci. 2017 Mar;20(3):265-271. doi: 10.22038/ijbms.2017.8354.
|
| 133 |
A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.Br J Cancer. 2000 May;82(9):1557-60. doi: 10.1054/bjoc.1999.1178.
|
| 134 |
Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer.Cancer Genet. 2015 Dec;208(12):595-601. doi: 10.1016/j.cancergen.2015.09.008. Epub 2015 Oct 9.
|
| 135 |
Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.Toxicol Appl Pharmacol. 2018 Aug 1;352:46-58. doi: 10.1016/j.taap.2018.05.026. Epub 2018 May 22.
|
| 136 |
Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.Cancer. 2014 Mar 15;120(6):808-17. doi: 10.1002/cncr.28491. Epub 2013 Nov 18.
|
| 137 |
(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity.Cancers (Basel). 2019 Dec 6;11(12):1964. doi: 10.3390/cancers11121964.
|
| 138 |
53BP1 regulates cell cycle arrest in esophageal cancer model.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):604-612. doi: 10.26355/eurrev_201901_16874.
|
| 139 |
TPX2 siRNA regulates growth and invasion of esophageal cancer cells.Biomed Pharmacother. 2014 Sep;68(7):833-9. doi: 10.1016/j.biopha.2014.08.008. Epub 2014 Aug 18.
|
| 140 |
An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-B Signaling.Cancer Res. 2018 Nov 15;78(22):6399-6412. doi: 10.1158/0008-5472.CAN-18-2063. Epub 2018 Sep 25.
|
| 141 |
TRPM8 facilitates proliferation and immune evasion of esophageal cancer cells.Biosci Rep. 2019 Oct 30;39(10):BSR20191878. doi: 10.1042/BSR20191878.
|
| 142 |
Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer.Oncol Lett. 2017 Jun;13(6):4245-4251. doi: 10.3892/ol.2017.6023. Epub 2017 Apr 11.
|
| 143 |
Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.J Cancer Res Clin Oncol. 2019 Feb;145(2):281-291. doi: 10.1007/s00432-019-02840-3. Epub 2019 Jan 17.
|
| 144 |
The FUS1 gene inhibits EC109 cell growth mediated by a lentivirus vector.Br J Biomed Sci. 2013;70(1):22-6. doi: 10.1080/09674845.2013.11669925.
|
| 145 |
Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.Exp Cell Res. 2019 Feb 15;375(2):41-50. doi: 10.1016/j.yexcr.2019.01.002. Epub 2019 Jan 3.
|
| 146 |
UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells.Oncotarget. 2017 Apr 4;8(14):23479-23491. doi: 10.18632/oncotarget.15182.
|
| 147 |
The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.J Mol Med (Berl). 2009 Mar;87(3):307-20. doi: 10.1007/s00109-008-0430-3. Epub 2008 Dec 16.
|
| 148 |
Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients.Med Oncol. 2013;30(3):630. doi: 10.1007/s12032-013-0630-8. Epub 2013 Jun 20.
|
| 149 |
High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.Oncology. 2009;76(5):342-9. doi: 10.1159/000209964. Epub 2009 Mar 23.
|
| 150 |
Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis.Mol Carcinog. 2019 Jan;58(1):42-54. doi: 10.1002/mc.22905. Epub 2018 Sep 21.
|
| 151 |
T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.Immunol Res. 2011 Aug;50(2-3):269-75. doi: 10.1007/s12026-011-8227-9.
|
| 152 |
Esophageal cancer risk is associated with polymorphisms of DNA repair genes MSH2 and WRN in Chinese population.J Thorac Oncol. 2012 Feb;7(2):448-52. doi: 10.1097/JTO.0b013e31823c487a.
|
| 153 |
X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF- signaling pathway in esophageal cancer cells.Cell Biosci. 2019 Sep 18;9:76. doi: 10.1186/s13578-019-0338-3. eCollection 2019.
|
| 154 |
ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines.J Radiat Res. 2008 Jul;49(4):399-407. doi: 10.1269/jrr.07096. Epub 2008 Apr 9.
|
| 155 |
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.Cancer Res. 2019 Nov 15;79(22):5734-5745. doi: 10.1158/0008-5472.CAN-18-3376. Epub 2019 Aug 7.
|
| 156 |
Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection.Curr Med Sci. 2019 Jun;39(3):385-390. doi: 10.1007/s11596-019-2047-x. Epub 2019 Jun 17.
|
| 157 |
Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer.Surgery. 2005 Aug;138(2):261-8. doi: 10.1016/j.surg.2005.04.011.
|
| 158 |
Up-regulation of Frizzled-7 (FZD7) in human gastric cancer.Int J Oncol. 2001 Jul;19(1):111-5.
|
| 159 |
Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.Cancer Res. 2001 Aug 1;61(15):5714-7.
|
| 160 |
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.Cancer Sci. 2007 Nov;98(11):1803-8. doi: 10.1111/j.1349-7006.2007.00603.x.
|
| 161 |
Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.Oncol Rep. 2006 Jun;15(6):1529-32.
|
| 162 |
Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.Clin Cancer Res. 1999 Dec;5(12):4073-8.
|
| 163 |
Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer.Gene. 2001 Jan 24;263(1-2):205-9. doi: 10.1016/s0378-1119(00)00570-9.
|
| 164 |
Effects of silencing the ATP-binding cassette protein E1 gene by electroporation on the proliferation and migration of EC109 human esophageal cancer cells.Mol Med Rep. 2015 Jul;12(1):837-42. doi: 10.3892/mmr.2015.3512. Epub 2015 Mar 19.
|
| 165 |
BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.Cancer Lett. 2016 Feb 1;371(1):125-33. doi: 10.1016/j.canlet.2015.11.031. Epub 2015 Dec 3.
|
| 166 |
High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.Int J Oncol. 2012 Jun;40(6):1789-96. doi: 10.3892/ijo.2012.1385. Epub 2012 Feb 22.
|
| 167 |
Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.Biomol Ther (Seoul). 2018 Jul 1;26(4):399-408. doi: 10.4062/biomolther.2017.113.
|
| 168 |
Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.Nutr Cancer. 2010;62(6):734-42. doi: 10.1080/01635581003605904.
|
| 169 |
Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population.Cancer Genet Cytogenet. 2005 May;159(1):48-52. doi: 10.1016/j.cancergencyto.2004.09.017.
|
| 170 |
NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma.Clin Cancer Res. 2008 Dec 1;14(23):7674-81. doi: 10.1158/1078-0432.CCR-08-0420.
|
| 171 |
Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.Mol Carcinog. 2018 Jan;57(1):78-88. doi: 10.1002/mc.22733. Epub 2017 Oct 9.
|
| 172 |
SULT1A1 polymorphism and esophageal cancer in males.Int J Cancer. 2003 Jan 1;103(1):101-4. doi: 10.1002/ijc.10805.
|
| 173 |
Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Oncol Rep. 2006 Jun;15(6):1551-5.
|
| 174 |
Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis.World J Surg Oncol. 2016 Jul 22;14(1):191. doi: 10.1186/s12957-016-0937-y.
|
| 175 |
A summary of meat intakes and health burdens.Eur J Clin Nutr. 2018 Jan;72(1):18-29. doi: 10.1038/ejcn.2017.117. Epub 2017 Aug 9.
|
| 176 |
MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation.Pharmazie. 2018 Jun 1;73(6):342-348. doi: 10.1691/ph.2018.7339.
|
| 177 |
The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.Int Immunopharmacol. 2017 May;46:75-79. doi: 10.1016/j.intimp.2017.02.027. Epub 2017 Mar 6.
|
| 178 |
Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer.Cancer Cell Int. 2018 Oct 22;18:168. doi: 10.1186/s12935-018-0657-1. eCollection 2018.
|
| 179 |
Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men.Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1227-33.
|
| 180 |
Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2006 Jun 28;12(24):3929-32. doi: 10.3748/wjg.v12.i24.3929.
|
| 181 |
Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9.Oncogene. 2007 Jan 4;26(1):148-57. doi: 10.1038/sj.onc.1209767. Epub 2006 Jun 26.
|
| 182 |
Cinobufagin Promotes Cell Cycle Arrest and Apoptosis to Block Human Esophageal Squamous Cell Carcinoma Cells Growth via the p73 Signalling Pathway.Biol Pharm Bull. 2019;42(9):1500-1509. doi: 10.1248/bpb.b19-00174.
|
| 183 |
Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.
|
| 184 |
CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics. 2010 Aug;11(8):1105-13. doi: 10.2217/pgs.10.76.
|
| 185 |
Ecrg4 deficiency extends the replicative capacity of neural stem cells in a Foxg1-dependent manner.Development. 2019 Feb 18;146(4):dev168120. doi: 10.1242/dev.168120.
|
| 186 |
Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.Genomics. 1999 Jul 15;59(2):234-42. doi: 10.1006/geno.1999.5857.
|
| 187 |
Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.Gene Ther. 2016 Jan;23(1):50-6. doi: 10.1038/gt.2015.84. Epub 2015 Aug 4.
|
| 188 |
Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.Oncol Lett. 2019 May;17(5):4351-4360. doi: 10.3892/ol.2019.10078. Epub 2019 Feb 26.
|
| 189 |
Immunohistochemical profile of ING3 protein in normal and cancerous tissues.Oncol Lett. 2017 Mar;13(3):1631-1636. doi: 10.3892/ol.2017.5632. Epub 2017 Jan 23.
|
| 190 |
Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11157-63. eCollection 2015.
|
| 191 |
High expression of leucinerich repeatcontaining8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.Oncol Rep. 2018 Sep;40(3):1275-1286. doi: 10.3892/or.2018.6556. Epub 2018 Jul 10.
|
| 192 |
Latent transforming growth factor -binding protein 4 is downregulated in esophageal cancer via promoter methylation.PLoS One. 2013 May 31;8(5):e65614. doi: 10.1371/journal.pone.0065614. Print 2013.
|
| 193 |
p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.Ann Surg Oncol. 2010 May;17(5):1453-8. doi: 10.1245/s10434-009-0882-x. Epub 2010 Jan 29.
|
| 194 |
Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis.Biochem Biophys Res Commun. 1997 Dec 18;241(2):481-5. doi: 10.1006/bbrc.1997.7818.
|
| 195 |
Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer.Clin Cancer Res. 1999 Dec;5(12):4233-41.
|
| 196 |
The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.Dis Esophagus. 1999;12(3):173-6. doi: 10.1046/j.1442-2050.1999.00042.x.
|
| 197 |
Decreased expression of SPRR3 in Chinese human oesophageal cancer.Carcinogenesis. 2000 Dec;21(12):2147-50. doi: 10.1093/carcin/21.12.2147.
|
| 198 |
Early diagnostic potential of APC hypermethylation in esophageal cancer.Cancer Manag Res. 2018 Feb 1;10:181-198. doi: 10.2147/CMAR.S148677. eCollection 2018.
|
| 199 |
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/-catenin pathway.J Transl Med. 2018 Jan 17;16(1):7. doi: 10.1186/s12967-018-1383-0.
|
| 200 |
Investigating the pathogenic role of PADI4 in oesophageal cancer.Int J Biol Sci. 2011;7(6):769-81. doi: 10.7150/ijbs.7.769. Epub 2011 Jun 11.
|
| 201 |
ERBB2 amplifications in esophageal adenocarcinoma.Ann Thorac Surg. 2004 Nov;78(5):1790-800. doi: 10.1016/j.athoracsur.2004.05.037.
|
| 202 |
High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers.Neoplasma. 2010;57(3):247-52. doi: 10.4149/neo_2010_03_247.
|
| 203 |
The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012.J Surg Oncol. 2017 Mar;115(3):296-300. doi: 10.1002/jso.24493. Epub 2016 Nov 4.
|
| 204 |
Leukocyte telomere length-related genetic variants in ACYP2 contribute to the risk of esophageal carcinoma in Chinese Han population.Oncotarget. 2017 Apr 11;8(15):25564-25570. doi: 10.18632/oncotarget.16071.
|
| 205 |
An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.Cancer Lett. 2018 May 28;422:118-128. doi: 10.1016/j.canlet.2018.02.031. Epub 2018 Feb 21.
|
| 206 |
Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma.Cancer Sci. 2010 Apr;101(4):1038-44. doi: 10.1111/j.1349-7006.2009.01477.x. Epub 2009 Dec 16.
|
| 207 |
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):111-7. doi: 10.1158/1055-9965.EPI-07-0407.
|
| 208 |
Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma.Dig Liver Dis. 2019 Oct;51(10):1475-1482. doi: 10.1016/j.dld.2019.04.018. Epub 2019 May 31.
|
| 209 |
Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression.Genet Mol Res. 2016 Jun 24;15(2). doi: 10.4238/gmr.15028318.
|
| 210 |
Vacuolar H(+)-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling.Cells. 2019 Sep 24;8(10):1137. doi: 10.3390/cells8101137.
|
| 211 |
Gene expression profiling and pathway network analysis of anti-tumor activity by Jaridon 6 in esophageal cancer.Eur J Pharmacol. 2017 Nov 15;815:478-486. doi: 10.1016/j.ejphar.2017.08.004. Epub 2017 Aug 9.
|
| 212 |
Expression of BAG-1 is closely related to cell differentiation and TNM stage in esophageal cancer and its downregulation inhibits the proliferation and invasion of human esophageal carcinoma cells.Oncol Rep. 2014 Oct;32(4):1441-6. doi: 10.3892/or.2014.3356. Epub 2014 Jul 23.
|
| 213 |
Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.Acta Oncol. 2018 Sep;57(9):1192-1200. doi: 10.1080/0284186X.2018.1450521. Epub 2018 Mar 12.
|
| 214 |
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics J. 2009 Jun;9(3):202-7. doi: 10.1038/tpj.2009.5. Epub 2009 Mar 10.
|
| 215 |
Expression of VRK1 and the downstream gene BANF1 in esophageal cancer.Biomed Pharmacother. 2017 May;89:1086-1091. doi: 10.1016/j.biopha.2017.02.095. Epub 2017 Mar 11.
|
| 216 |
miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.Oncol Rep. 2018 Jan;39(1):71-80. doi: 10.3892/or.2017.6064. Epub 2017 Nov 1.
|
| 217 |
Down-regulation of Bcl-XL by RNA interference suppresses cell growth and induces apoptosis in human esophageal cancer cells.World J Gastroenterol. 2006 Dec 14;12(46):7472-7. doi: 10.3748/wjg.v12.i46.7472.
|
| 218 |
Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.Oncotarget. 2016 Apr 12;7(15):19960-74. doi: 10.18632/oncotarget.6963.
|
| 219 |
A role for the clock period circadian regulator 2 gene in regulating the clock gene network in human oral squamous cell carcinoma cells.Oncol Lett. 2018 Apr;15(4):4185-4192. doi: 10.3892/ol.2018.7825. Epub 2018 Jan 19.
|
| 220 |
MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2.Biomed Pharmacother. 2018 Sep;105:582-589. doi: 10.1016/j.biopha.2018.05.152. Epub 2018 Jun 8.
|
| 221 |
Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying 1-integrin glycosylation.J Cancer. 2018 Jun 23;9(15):2666-2677. doi: 10.7150/jca.25252. eCollection 2018.
|
| 222 |
CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma.Cancer Lett. 2002 May 8;179(1):71-7. doi: 10.1016/s0304-3835(01)00846-1.
|
| 223 |
The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Oncol Rep. 2007 Sep;18(3):601-9.
|
| 224 |
CBX8, a novel DNA repair protein, promotes tumorigenesis in human esophageal carcinoma.Int J Clin Exp Pathol. 2014 Jul 15;7(8):4817-26. eCollection 2014.
|
| 225 |
Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer.Int J Cancer. 2007 Apr 15;120(8):1739-47. doi: 10.1002/ijc.22463.
|
| 226 |
Circulating Inflammation Markers and Risk of Gastric and Esophageal Cancers: A Case-Cohort Study Within the Japan Public Health Center-Based Prospective Study.Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):829-832. doi: 10.1158/1055-9965.EPI-18-1157. Epub 2019 Mar 15.
|
| 227 |
WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice.PLoS One. 2014 Apr 11;9(4):e94751. doi: 10.1371/journal.pone.0094751. eCollection 2014.
|
| 228 |
Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.Tumour Biol. 2014 Apr;35(4):3355-62. doi: 10.1007/s13277-013-1442-3. Epub 2013 Dec 3.
|
| 229 |
Role of interleukin 1 beta in esophageal squamous cell carcinoma.J Mol Med (Berl). 2012 Jan;90(1):89-100. doi: 10.1007/s00109-011-0809-4. Epub 2011 Sep 13.
|
| 230 |
Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S640-7. doi: 10.1245/s10434-014-3740-4. Epub 2014 May 22.
|
| 231 |
PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.PLoS One. 2015 Oct 21;10(10):e0140451. doi: 10.1371/journal.pone.0140451. eCollection 2015.
|
| 232 |
LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis.Eur Rev Med Pharmacol Sci. 2018 May;22(9):2653-2661. doi: 10.26355/eurrev_201805_14961.
|
| 233 |
CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer.Cancer Manag Res. 2019 Apr 15;11:3253-3264. doi: 10.2147/CMAR.S193793. eCollection 2019.
|
| 234 |
Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.Oncogene. 2016 Apr 21;35(16):2087-97. doi: 10.1038/onc.2015.271. Epub 2015 Aug 3.
|
| 235 |
ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.Life Sci. 2019 Sep 1;232:116679. doi: 10.1016/j.lfs.2019.116679. Epub 2019 Jul 21.
|
| 236 |
Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).PLoS One. 2014 Mar 12;9(3):e90836. doi: 10.1371/journal.pone.0090836. eCollection 2014.
|
| 237 |
Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.Dis Esophagus. 2013 Sep-Oct;26(7):729-36. doi: 10.1111/dote.12013. Epub 2013 Jan 10.
|
| 238 |
Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.J Oral Pathol Med. 2017 Sep;46(8):583-590. doi: 10.1111/jop.12538. Epub 2017 Jun 5.
|
| 239 |
High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.BMC Gastroenterol. 2017 Feb 17;17(1):33. doi: 10.1186/s12876-017-0590-0.
|
| 240 |
The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.Oncotarget. 2016 Feb 2;7(5):5495-506. doi: 10.18632/oncotarget.6747.
|
| 241 |
Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression.Esophagus. 2020 Apr;17(2):159-167. doi: 10.1007/s10388-019-00695-8. Epub 2019 Oct 8.
|
| 242 |
CRCT1 regulated by microRNA-520g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.Tumour Biol. 2016 Jun;37(6):8271-9. doi: 10.1007/s13277-015-4730-2. Epub 2015 Dec 30.
|
| 243 |
Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.World J Gastroenterol. 2013 Jul 14;19(26):4127-36. doi: 10.3748/wjg.v19.i26.4127.
|
| 244 |
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.Genes Chromosomes Cancer. 2006 Apr;45(4):392-400. doi: 10.1002/gcc.20298.
|
| 245 |
C-terminal binding protein? mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.Int J Oncol. 2018 Jul;53(1):167-176. doi: 10.3892/ijo.2018.4367. Epub 2018 Apr 12.
|
| 246 |
Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through Targeting CTNNA2.DNA Cell Biol. 2019 Feb;38(2):151-161. doi: 10.1089/dna.2018.4377. Epub 2018 Dec 8.
|
| 247 |
Cortactin as a potential predictor of second esophageal neoplasia in hypopharyngeal carcinoma.Auris Nasus Larynx. 2019 Apr;46(2):260-266. doi: 10.1016/j.anl.2018.08.002. Epub 2018 Aug 11.
|
| 248 |
Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Int J Clin Oncol. 2020 Mar;25(3):446-455. doi: 10.1007/s10147-019-01547-2. Epub 2019 Sep 18.
|
| 249 |
Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer.Gastroenterol Res Pract. 2017;2017:1678584. doi: 10.1155/2017/1678584. Epub 2017 Jun 27.
|
| 250 |
High incidence of coding gene mutations in mitochondrial DNA in esophageal cancer.Mol Med Rep. 2017 Dec;16(6):8537-8541. doi: 10.3892/mmr.2017.7663. Epub 2017 Sep 29.
|
| 251 |
Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF- signaling.PLoS One. 2014 Apr 17;9(4):e95509. doi: 10.1371/journal.pone.0095509. eCollection 2014.
|
| 252 |
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.J Biomed Sci. 2017 Jan 11;24(1):6. doi: 10.1186/s12929-016-0308-6.
|
| 253 |
Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.Ann Surg Oncol. 2009 May;16(5):1378-83. doi: 10.1245/s10434-009-0356-1. Epub 2009 Feb 18.
|
| 254 |
Overexpression of degenerative spermatocyte homolog 1 up-regulates the expression of cyclin D1 and enhances metastatic efficiency in esophageal carcinoma Eca109 cells.Mol Carcinog. 2009 Oct;48(10):886-94. doi: 10.1002/mc.20533.
|
| 255 |
Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.Gastroenterology. 2015 Dec;149(7):1825-1836.e5. doi: 10.1053/j.gastro.2015.08.025. Epub 2015 Aug 22.
|
| 256 |
Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.Hum Pathol. 2010 Oct;41(10):1456-65. doi: 10.1016/j.humpath.2010.04.003.
|
| 257 |
Biological properties of biopsy specimens are useful for predicting lymph node micrometastasis in esophageal carcinoma.Anticancer Res. 2002 Sep-Oct;22(5):2951-6.
|
| 258 |
Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma.Br J Cancer. 2004 Jul 19;91(2):282-6. doi: 10.1038/sj.bjc.6601941.
|
| 259 |
Elongation factor 1 gamma mRNA expression in oesophageal carcinoma.Gut. 1996 Jan;38(1):66-70. doi: 10.1136/gut.38.1.66.
|
| 260 |
Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.Dig Liver Dis. 2007 Aug;39(8):725-32. doi: 10.1016/j.dld.2007.05.013. Epub 2007 Jul 3.
|
| 261 |
The biological function of long noncoding RNA FAL1 in oesophageal carcinoma cells.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):896-903. doi: 10.1080/21691401.2019.1573738.
|
| 262 |
EMP3 as a candidate tumor suppressor gene for solid tumors.Expert Opin Ther Targets. 2009 Jul;13(7):811-22. doi: 10.1517/14728220902988549.
|
| 263 |
Transcriptional regulation of miR-146b by C/EBP LAP2 in esophageal cancer cells.Biochem Biophys Res Commun. 2014 Mar 28;446(1):267-71. doi: 10.1016/j.bbrc.2014.02.096. Epub 2014 Feb 28.
|
| 264 |
Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype.Oncol Lett. 2018 Aug;16(2):2539-2548. doi: 10.3892/ol.2018.8894. Epub 2018 Jun 4.
|
| 265 |
Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.Front Oncol. 2019 Feb 21;9:85. doi: 10.3389/fonc.2019.00085. eCollection 2019.
|
| 266 |
Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.Oncol Rep. 2004 Oct;12(4):827-31.
|
| 267 |
Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.J Exp Clin Cancer Res. 2009 Nov 25;28(1):145. doi: 10.1186/1756-9966-28-145.
|
| 268 |
FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.J Cell Mol Med. 2019 Feb;23(2):1375-1385. doi: 10.1111/jcmm.14040. Epub 2018 Dec 18.
|
| 269 |
Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer.Acta Oncol. 2017 Nov;56(11):1495-1500. doi: 10.1080/0284186X.2017.1349928. Epub 2017 Aug 25.
|
| 270 |
Nonsynonymous polymorphisms in FAT4 gene are associated with the risk of esophageal cancer in an Eastern Chinese population.Int J Cancer. 2013 Jul 15;133(2):357-61. doi: 10.1002/ijc.28033. Epub 2013 Feb 12.
|
| 271 |
Migfilin regulates esophageal cancer cell motility through promoting GSK-3-mediated degradation of -catenin.Mol Cancer Res. 2012 Mar;10(3):273-81. doi: 10.1158/1541-7786.MCR-11-0419. Epub 2012 Jan 13.
|
| 272 |
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance.Theranostics. 2019 Feb 28;9(6):1599-1613. doi: 10.7150/thno.30372. eCollection 2019.
|
| 273 |
Aberrant methylation and decreased expression of the TGF-/Smad target gene FBXO32 in esophageal squamous cell carcinoma.Cancer. 2014 Aug 15;120(16):2412-23. doi: 10.1002/cncr.28764. Epub 2014 May 2.
|
| 274 |
The Effect of FERMT1 Regulated by miR-24 on the Growth and Radiation Resistance of Esophageal Cancer.J Biomed Nanotechnol. 2019 Mar 1;15(3):621-631. doi: 10.1166/jbn.2019.2711.
|
| 275 |
Differential expression of Kindlin-1 and Kindlin-2 correlates with esophageal cancer progression and epidemiology.Sci China Life Sci. 2017 Nov;60(11):1214-1222. doi: 10.1007/s11427-016-9044-5. Epub 2017 Jun 29.
|
| 276 |
Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer.Radiat Oncol. 2019 Feb 4;14(1):27. doi: 10.1186/s13014-019-1232-1.
|
| 277 |
Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.OMICS. 2017 Oct;21(10):616-631. doi: 10.1089/omi.2017.0116.
|
| 278 |
NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.Cancer Lett. 2016 Sep 28;380(1):47-58. doi: 10.1016/j.canlet.2016.06.009. Epub 2016 Jun 15.
|
| 279 |
Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations.J Exp Clin Cancer Res. 2015 Jul 25;34(1):70. doi: 10.1186/s13046-015-0185-y.
|
| 280 |
Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.Int J Cancer. 2013 Oct 1;133(7):1751-5. doi: 10.1002/ijc.28160. Epub 2013 Apr 16.
|
| 281 |
FOXK1 plays an oncogenic role in the development of esophageal cancer.Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):88-94. doi: 10.1016/j.bbrc.2017.10.080. Epub 2017 Oct 16.
|
| 282 |
Molecular cloning and expression of proto-oncogene FRAT1 in human cancer.Int J Oncol. 2002 Apr;20(4):785-9.
|
| 283 |
The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3 activity in cell growth of esophageal carcinoma.Tumour Biol. 2014 Feb;35(2):995-1002. doi: 10.1007/s13277-013-1133-0.
|
| 284 |
Effect of GDF11 on proliferation and apoptosis of esophageal cancer cells.Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):80-84.
|
| 285 |
MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma.Mol Genet Genomics. 2014 Dec;289(6):1123-30. doi: 10.1007/s00438-014-0873-x. Epub 2014 Jun 12.
|
| 286 |
RMP promotes the proliferation and radioresistance of esophageal carcinoma.J Cancer. 2019 Jun 9;10(16):3698-3705. doi: 10.7150/jca.32680. eCollection 2019.
|
| 287 |
Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma.Cancer Sci. 2012 Feb;103(2):233-8. doi: 10.1111/j.1349-7006.2011.02142.x. Epub 2011 Dec 8.
|
| 288 |
Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma.Clin Cancer Res. 2019 May 15;25(10):3035-3045. doi: 10.1158/1078-0432.CCR-18-3169. Epub 2019 Feb 11.
|
| 289 |
High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.PLoS One. 2012;7(10):e45622. doi: 10.1371/journal.pone.0045622. Epub 2012 Oct 2.
|
| 290 |
High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.
|
| 291 |
Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies.World J Gastroenterol. 2016 Feb 7;22(5):1911-8. doi: 10.3748/wjg.v22.i5.1911.
|
| 292 |
RNAi screening identifies HAT1 as a potential drug target in esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2014 Jun 15;7(7):3898-907. eCollection 2014.
|
| 293 |
miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer.Biochem Biophys Res Commun. 2017 Apr 1;485(2):506-512. doi: 10.1016/j.bbrc.2017.02.016. Epub 2017 Feb 9.
|
| 294 |
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.Cancer Sci. 2019 Oct;110(10):3049-3060. doi: 10.1111/cas.14165. Epub 2019 Sep 19.
|
| 295 |
Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus.Tumour Biol. 2014 May;35(5):4907-12. doi: 10.1007/s13277-014-1644-3. Epub 2014 Jan 29.
|
| 296 |
Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers.Cancer Res. 2008 Feb 15;68(4):1136-43. doi: 10.1158/0008-5472.CAN-07-5021.
|
| 297 |
Associations between polymorphisms in IL-12A, IL-12B, IL-12R1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer.J Cancer Res Clin Oncol. 2012 Nov;138(11):1891-900. doi: 10.1007/s00432-012-1269-0. Epub 2012 Jun 28.
|
| 298 |
Effect and mechanism of PAR-2 on the proliferation of esophageal cancer cells.Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4688-4696.
|
| 299 |
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity invitro.Oncol Rep. 2015 Nov;34(5):2325-32. doi: 10.3892/or.2015.4211. Epub 2015 Aug 20.
|
| 300 |
Down-regulation in human cancers of DRHC, a novel helicase-like gene from 17q25.1 that inhibits cell growth.Cancer Lett. 2003 Apr 10;193(1):41-7. doi: 10.1016/s0304383502006882.
|
| 301 |
Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.FASEB J. 2019 Sep;33(9):10490-10504. doi: 10.1096/fj.201802543RR. Epub 2019 Jul 15.
|
| 302 |
Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.Oncol Res. 2016;24(4):247-53. doi: 10.3727/096504016X14652175055765.
|
| 303 |
LMX1B involved in the radioresistance, proliferation and migration of esophageal cancer cells.Biomed Pharmacother. 2019 Oct;118:109358. doi: 10.1016/j.biopha.2019.109358. Epub 2019 Aug 29.
|
| 304 |
Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway.Oncol Lett. 2017 Oct;14(4):4897-4905. doi: 10.3892/ol.2017.6790. Epub 2017 Aug 23.
|
| 305 |
The role of NRAGE subcellular location and epithelial-mesenchymal transition on radiation resistance of esophageal carcinoma cell.J Cancer Res Ther. 2018 Jan;14(1):46-51. doi: 10.4103/jcrt.JCRT_687_17.
|
| 306 |
Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.Dis Esophagus. 2015 Feb-Mar;28(2):188-95. doi: 10.1111/dote.12156. Epub 2013 Oct 21.
|
| 307 |
MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.Sci Rep. 2013 Oct 3;3:2838. doi: 10.1038/srep02838.
|
| 308 |
Role of MAML1 in targeted therapy against the esophageal cancer stem cells.J Transl Med. 2019 Apr 16;17(1):126. doi: 10.1186/s12967-019-1876-5.
|
| 309 |
Inhibition of alpha-mannosidase Man2c1 gene expression suppresses growth of esophageal carcinoma cells through mitotic arrest and apoptosis.Cancer Sci. 2008 Dec;99(12):2428-34. doi: 10.1111/j.1349-7006.2008.01019.x. Epub 2008 Nov 19.
|
| 310 |
Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.Cancer Lett. 2019 Feb 1;442:126-136. doi: 10.1016/j.canlet.2018.10.016. Epub 2018 Nov 2.
|
| 311 |
Selective En Masse Ligation of the ThoracicDuct to Prevent Chyle Leak AfterEsophagectomy.Ann Thorac Surg. 2017 Jun;103(6):1802-1807. doi: 10.1016/j.athoracsur.2017.01.025. Epub 2017 Apr 3.
|
| 312 |
Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.Medicine (Baltimore). 2019 Mar;98(13):e14855. doi: 10.1097/MD.0000000000014855.
|
| 313 |
Increased expression of MARCH8, an E3 ubiquitin ligase, is associated with growth of esophageal tumor.Cancer Cell Int. 2017 Dec 4;17:116. doi: 10.1186/s12935-017-0490-y. eCollection 2017.
|
| 314 |
Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics.IUBMB Life. 2019 Feb;71(2):254-260. doi: 10.1002/iub.1971. Epub 2018 Nov 30.
|
| 315 |
The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.Cells. 2019 Oct 30;8(11):1357. doi: 10.3390/cells8111357.
|
| 316 |
Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.Cancer Lett. 2018 Apr 1;418:97-108. doi: 10.1016/j.canlet.2018.01.022. Epub 2018 Jan 10.
|
| 317 |
Effects of metallothionein-3 and metallothionein-1E gene transfection on proliferation, cell cycle, and apoptosis of esophageal cancer cells.Genet Mol Res. 2013 Oct 17;12(4):4595-603. doi: 10.4238/2013.October.17.2.
|
| 318 |
The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.Scand J Gastroenterol. 2018 May;53(5):533-540. doi: 10.1080/00365521.2017.1407440. Epub 2017 Nov 24.
|
| 319 |
Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.J Clin Lab Anal. 2018 Feb;32(2):e22248. doi: 10.1002/jcla.22248. Epub 2017 May 2.
|
| 320 |
Association between genetic variants and esophageal cancer risk.Oncotarget. 2017 Jul 18;8(29):47167-47174. doi: 10.18632/oncotarget.17006.
|
| 321 |
A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.Cancer. 2013 Dec 1;119(23):4205-11. doi: 10.1002/cncr.28338. Epub 2013 Sep 10.
|
| 322 |
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.J Thorac Oncol. 2016 Nov;11(11):1912-1926. doi: 10.1016/j.jtho.2016.06.015. Epub 2016 Jun 30.
|
| 323 |
Nkx2-8 downregulation promotes angiogenesis and activates NF-B in esophageal cancer.Cancer Res. 2013 Jun 15;73(12):3638-48. doi: 10.1158/0008-5472.CAN-12-4028. Epub 2013 Apr 19.
|
| 324 |
Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.Cancer Sci. 2017 May;108(5):910-917. doi: 10.1111/cas.13204. Epub 2017 Apr 24.
|
| 325 |
MicroRNA-548-3p and MicroRNA-576-5p enhance the migration and invasion of esophageal squamous cell carcinoma cells via NRIP1 down-regulation.Neoplasma. 2018 Nov 15;65(6):881-887. doi: 10.4149/neo_2018_171206N803. Epub 2018 Jun 17.
|
| 326 |
Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.Cancer Sci. 2012 Mar;103(3):577-86. doi: 10.1111/j.1349-7006.2011.02167.x. Epub 2012 Jan 9.
|
| 327 |
Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer.Front Oncol. 2019 Mar 15;9:147. doi: 10.3389/fonc.2019.00147. eCollection 2019.
|
| 328 |
OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.Oncogene. 2018 Jun;37(25):3356-3368. doi: 10.1038/s41388-018-0224-1. Epub 2018 Mar 21.
|
| 329 |
Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.Epigenetics. 2008 Nov;3(6):336-41. doi: 10.4161/epi.3.6.7158. Epub 2008 Nov 8.
|
| 330 |
Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2018 Apr;15(4):5703-5711. doi: 10.3892/ol.2018.8004. Epub 2018 Feb 8.
|
| 331 |
FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.Am J Cancer Res. 2017 Aug 1;7(8):1642-1653. eCollection 2017.
|
| 332 |
Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.Lab Invest. 2013 Dec;93(12):1276-87. doi: 10.1038/labinvest.2013.124. Epub 2013 Oct 21.
|
| 333 |
Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1513-1519. doi: 10.26355/eurrev_201902_17109.
|
| 334 |
Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6.J BUON. 2019 Mar-Apr;24(2):805-812.
|
| 335 |
PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo.Onco Targets Ther. 2019 Nov 18;12:9899-9913. doi: 10.2147/OTT.S226851. eCollection 2019.
|
| 336 |
Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma.Cancer Biother Radiopharm. 2015 Apr;30(3):139-45. doi: 10.1089/cbr.2014.1701. Epub 2015 Mar 16.
|
| 337 |
Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells.Cancer Gene Ther. 2015 Apr;22(3):138-44. doi: 10.1038/cgt.2014.77. Epub 2015 Jan 16.
|
| 338 |
Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclinD1.Oncol Rep. 2016 Jun;35(6):3532-40. doi: 10.3892/or.2016.4731. Epub 2016 Apr 4.
|
| 339 |
PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKC/NF-B Pathway.Yonsei Med J. 2018 Dec;59(10):1159-1165. doi: 10.3349/ymj.2018.59.10.1159.
|
| 340 |
Overexpression of DNA polymerase iota (Pol) in esophageal squamous cell carcinoma.Cancer Sci. 2012 Aug;103(8):1574-9. doi: 10.1111/j.1349-7006.2012.02309.x. Epub 2012 May 30.
|
| 341 |
The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
|
| 342 |
Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.Mol Carcinog. 2018 Jul;57(7):886-895. doi: 10.1002/mc.22809. Epub 2018 Apr 6.
|
| 343 |
Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells.BMC Cell Biol. 2011 Sep 27;12:41. doi: 10.1186/1471-2121-12-41.
|
| 344 |
Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.Cell Death Dis. 2019 Dec 5;10(12):930. doi: 10.1038/s41419-019-2171-3.
|
| 345 |
PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.Anticancer Res. 2018 Nov;38(11):6139-6145. doi: 10.21873/anticanres.12966.
|
| 346 |
Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation.Acta Pharmacol Sin. 2011 Apr;32(4):528-36. doi: 10.1038/aps.2010.235.
|
| 347 |
POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim.Neoplasia. 2018 May;20(5):411-424. doi: 10.1016/j.neo.2018.02.005. Epub 2018 Mar 21.
|
| 348 |
PSMD4 regulates the malignancy of esophageal cancer cells by suppressing endoplasmic reticulum stress.Kaohsiung J Med Sci. 2019 Oct;35(10):591-597. doi: 10.1002/kjm2.12093. Epub 2019 Jun 4.
|
| 349 |
PBF, a Proto-oncogene in Esophageal Carcinoma.Open Med (Wars). 2019 Oct 13;14:748-756. doi: 10.1515/med-2019-0086. eCollection 2019.
|
| 350 |
miR-144 functions as an oncomiR in KYSE-410 human esophageal carcinoma cell line in vitro and targets PURA.Neoplasma. 2018;65(4):542-551. doi: 10.4149/neo_2018_170814N535.
|
| 351 |
Expression of paxillin and FAK mRNA and the related clinical significance in esophageal carcinoma.Mol Med Rep. 2012 Feb;5(2):469-72. doi: 10.3892/mmr.2011.664. Epub 2011 Nov 4.
|
| 352 |
Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-beta2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A.Mol Cancer. 2010 Apr 28;9:93. doi: 10.1186/1476-4598-9-93.
|
| 353 |
Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma.Oncology. 2019;97(3):155-163. doi: 10.1159/000500592. Epub 2019 Jun 19.
|
| 354 |
Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.Carcinogenesis. 2009 May;30(5):785-92. doi: 10.1093/carcin/bgp058. Epub 2009 Mar 6.
|
| 355 |
Knockdown of Rad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells.Tumour Biol. 2016 Jan;37(1):963-70. doi: 10.1007/s13277-015-3879-z. Epub 2015 Aug 12.
|
| 356 |
Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.Med Sci Monit. 2016 Aug 10;22:2816-24. doi: 10.12659/msm.896877.
|
| 357 |
Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.Discov Med. 2014 Apr;17(94):169-78.
|
| 358 |
Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2016 Jan;33(1):73-85. doi: 10.1007/s10585-015-9759-5.
|
| 359 |
Proliferation Potential-Related Protein Promotes the Esophageal Cancer Cell Proliferation, Migration and Suppresses Apoptosis by Mediating the Expression of p53 and Interleukin-17.Pathobiology. 2018;85(5-6):322-331. doi: 10.1159/000492393. Epub 2018 Sep 17.
|
| 360 |
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.BMC Cancer. 2018 Nov 12;18(1):1106. doi: 10.1186/s12885-018-5032-z.
|
| 361 |
Natural antisense transcript TPM1-AS regulates the alternative splicing of tropomyosin I through an interaction with RNA-binding motif protein 4.Int J Biochem Cell Biol. 2017 Sep;90:59-67. doi: 10.1016/j.biocel.2017.07.017. Epub 2017 Jul 25.
|
| 362 |
Retinoblastoma-binding protein 2 induces epithelial-mesenchymal transition in esophageal squamous cancer cells.Biotechnol Lett. 2015 Dec;37(12):2365-70. doi: 10.1007/s10529-015-1925-y. Epub 2015 Aug 12.
|
| 363 |
Targeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cells.Oncotarget. 2017 Apr 25;8(17):29125-29137. doi: 10.18632/oncotarget.16250.
|
| 364 |
SLC52A3 expression is activated by NF-B p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.Cell Mol Life Sci. 2018 Jul;75(14):2643-2661. doi: 10.1007/s00018-018-2757-4. Epub 2018 Feb 10.
|
| 365 |
RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis.Clin Exp Metastasis. 2011 Aug;28(6):541-9. doi: 10.1007/s10585-011-9390-z. Epub 2011 May 1.
|
| 366 |
Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung.Biochem Cell Biol. 2019 Oct;97(5):589-599. doi: 10.1139/bcb-2018-0252. Epub 2019 Jan 23.
|
| 367 |
Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway.Biochem Biophys Res Commun. 2018 Apr 6;498(3):424-430. doi: 10.1016/j.bbrc.2018.02.167. Epub 2018 Mar 15.
|
| 368 |
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.Cell Physiol Biochem. 2017;42(6):2267-2280. doi: 10.1159/000480000. Epub 2017 Aug 17.
|
| 369 |
Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo.Biosci Rep. 2019 May 7;39(5):BSR20182448. doi: 10.1042/BSR20182448. Print 2019 May 31.
|
| 370 |
Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.Anticancer Res. 2013 Nov;33(11):5199-203.
|
| 371 |
siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.World J Gastroenterol. 2012 Aug 21;18(31):4127-35. doi: 10.3748/wjg.v18.i31.4127.
|
| 372 |
Expression and significance of RRBP1 in esophageal carcinoma.Cancer Manag Res. 2018 May 17;10:1243-1249. doi: 10.2147/CMAR.S158013. eCollection 2018.
|
| 373 |
A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.Int J Oncol. 2007 Feb;30(2):421-8.
|
| 374 |
S100A14: novel modulator of terminal differentiation in esophageal cancer.Mol Cancer Res. 2013 Dec;11(12):1542-53. doi: 10.1158/1541-7786.MCR-13-0317. Epub 2013 Oct 9.
|
| 375 |
Expression and clinical significance of S100A2 and p63 in esophageal carcinoma.World J Gastroenterol. 2009 Sep 7;15(33):4183-8. doi: 10.3748/wjg.15.4183.
|
| 376 |
Genetic epidemiological analysis of esophageal cancer in high-incidence areas of China.Asian Pac J Cancer Prev. 2014;15(22):9859-63. doi: 10.7314/apjcp.2014.15.22.9859.
|
| 377 |
mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.J Cancer. 2017 Feb 25;8(4):646-656. doi: 10.7150/jca.15652. eCollection 2017.
|
| 378 |
A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells.Anticancer Agents Med Chem. 2018;18(3):394-400. doi: 10.2174/1871520617666170522123742.
|
| 379 |
Analysis of Sciellin (SCEL) as a candidate gene in esophageal squamous cell carcinoma.Anticancer Res. 2004 May-Jun;24(3a):1417-9.
|
| 380 |
SEL1L and squamous cell carcinoma of the esophagus.Clin Cancer Res. 2004 Sep 1;10(17):5857-61. doi: 10.1158/1078-0432.CCR-04-0075.
|
| 381 |
Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.
|
| 382 |
High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.Pathol Int. 2018 Dec;68(12):685-693. doi: 10.1111/pin.12736. Epub 2018 Dec 5.
|
| 383 |
Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy.Sci Rep. 2017 Feb 7;7:42060. doi: 10.1038/srep42060.
|
| 384 |
Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.Anticancer Drugs. 2019 Jul;30(6):596-603. doi: 10.1097/CAD.0000000000000751.
|
| 385 |
MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5.Scand J Gastroenterol. 2018 Jun-Jul;53(7):769-776. doi: 10.1080/00365521.2018.1476913. Epub 2018 May 31.
|
| 386 |
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.Sci Rep. 2019 Aug 12;9(1):11661. doi: 10.1038/s41598-019-48152-x.
|
| 387 |
EGF-induced C/EBP participates in EMT by decreasing the expression of miR-203 in esophageal squamous cell carcinoma cells.J Cell Sci. 2014 Sep 1;127(Pt 17):3735-44. doi: 10.1242/jcs.148759. Epub 2014 Jul 2.
|
| 388 |
SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.J Biomed Sci. 2019 Feb 18;26(1):20. doi: 10.1186/s12929-019-0510-4.
|
| 389 |
lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.Oncol Rep. 2016 Nov;36(5):2960-2966. doi: 10.3892/or.2016.5121. Epub 2016 Sep 22.
|
| 390 |
Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.Clin Cancer Res. 2011 Jan 1;17(1):46-55. doi: 10.1158/1078-0432.CCR-10-1155. Epub 2010 Nov 17.
|
| 391 |
A novel tumor suppressor SPINK5 targets Wnt/-catenin signaling pathway in esophageal cancer.Cancer Med. 2019 May;8(5):2360-2371. doi: 10.1002/cam4.2078. Epub 2019 Mar 13.
|
| 392 |
ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA.World J Gastroenterol. 2017 Mar 14;23(10):1796-1803. doi: 10.3748/wjg.v23.i10.1796.
|
| 393 |
EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.Target Oncol. 2014 Mar;9(1):43-52. doi: 10.1007/s11523-013-0260-2. Epub 2013 Feb 2.
|
| 394 |
An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma.Oncogene. 2003 Jan 23;22(3):467-70. doi: 10.1038/sj.onc.1206125.
|
| 395 |
Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.Cancer Res. 2008 Feb 15;68(4):1074-82. doi: 10.1158/0008-5472.CAN-07-0964.
|
| 396 |
miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma.Int J Oncol. 2015 May;46(5):2163-71. doi: 10.3892/ijo.2015.2900. Epub 2015 Feb 19.
|
| 397 |
LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China.Carcinogenesis. 2005 Jul;26(7):1280-4. doi: 10.1093/carcin/bgi071. Epub 2005 Mar 17.
|
| 398 |
Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2018 Jun 17;24:4128-4136. doi: 10.12659/MSM.909138.
|
| 399 |
Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer.J Thorac Dis. 2017 Nov;9(11):4461-4476. doi: 10.21037/jtd.2017.10.60.
|
| 400 |
Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.J Cancer Res Clin Oncol. 1999;125(2):71-6. doi: 10.1007/s004320050244.
|
| 401 |
Methylation of TFPI-2 is an early event of esophageal carcinogenesis.Epigenomics. 2012 Apr;4(2):135-46. doi: 10.2217/epi.12.11.
|
| 402 |
Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154.
|
| 403 |
NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.Cancer Biol Ther. 2016 Sep;17(9):943-54. doi: 10.1080/15384047.2016.1210734. Epub 2016 Jul 14.
|
| 404 |
TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.Oncotarget. 2017 Mar 21;8(12):19274-19284. doi: 10.18632/oncotarget.13866.
|
| 405 |
Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.Oncotarget. 2017 Jul 25;8(41):70035-70048. doi: 10.18632/oncotarget.19550. eCollection 2017 Sep 19.
|
| 406 |
Effects of NGX6 expression on proliferation and invasion of nasopharyngeal carcinoma cells and survival of patients.Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5378-5385. doi: 10.26355/eurrev_201712_13923.
|
| 407 |
Relationship between transmembrane serine protease expression and prognosis of esophageal squamous cell carcinoma.J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1067-1072.
|
| 408 |
Thymosin beta-10 gene overexpression is a general event in human carcinogenesis.Am J Pathol. 1999 Sep;155(3):799-804. doi: 10.1016/s0002-9440(10)65178-4.
|
| 409 |
Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.
|
| 410 |
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.Cancer Sci. 2018 Oct;109(10):3080-3092. doi: 10.1111/cas.13762. Epub 2018 Aug 28.
|
| 411 |
TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLC.Oncol Rep. 2019 Apr;41(4):2117-2125. doi: 10.3892/or.2019.6989. Epub 2019 Jan 30.
|
| 412 |
Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.Neoplasia. 2003 Mar-Apr;5(2):121-7. doi: 10.1016/s1476-5586(03)80003-9.
|
| 413 |
Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.J Toxicol Environ Health A. 2007 Jun;70(11):885-94. doi: 10.1080/15287390701285915.
|
| 414 |
Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.Am J Surg. 2007 Sep;194(3):380-4. doi: 10.1016/j.amjsurg.2007.01.026.
|
| 415 |
Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer.Carcinogenesis. 2002 Oct;23(10):1695-9. doi: 10.1093/carcin/23.10.1695.
|
| 416 |
Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.World J Gastroenterol. 2006 Oct 7;12(37):6041-5. doi: 10.3748/wjg.v12.i37.6041.
|
| 417 |
Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray.World J Gastroenterol. 2003 Mar;9(3):392-8. doi: 10.3748/wjg.v9.i3.392.
|
| 418 |
Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.Cancer Invest. 1997;15(5):411-5. doi: 10.3109/07357909709047579.
|
| 419 |
Serological identification of tumor antigens of esophageal squamous cell carcinoma.Int J Oncol. 2005 Jan;26(1):77-86.
|
| 420 |
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.J Chemother. 2006 Oct;18(5):514-24. doi: 10.1179/joc.2006.18.5.514.
|
| 421 |
Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation.Lab Invest. 2004 Oct;84(10):1289-304. doi: 10.1038/labinvest.3700159.
|
| 422 |
Negative implication of C-MYC as an amplification target in esophageal cancer.Cancer Genet Cytogenet. 2006 Feb;165(1):20-4. doi: 10.1016/j.cancergencyto.2005.07.009.
|
| 423 |
Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates.Br J Cancer. 2004 Aug 16;91(4):714-9. doi: 10.1038/sj.bjc.6602028.
|
| 424 |
Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer.World J Gastroenterol. 2006 Sep 7;12(33):5281-6. doi: 10.3748/wjg.v12.i33.5281.
|
| 425 |
Molecular cloning and characterization of OSR1 on human chromosome 2p24.Int J Mol Med. 2002 Aug;10(2):221-5.
|
| 426 |
Hypermethylation of the GATA gene family in esophageal cancer.Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092.
|
| 427 |
Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.Pathol Int. 2007 Oct;57(10):672-80. doi: 10.1111/j.1440-1827.2007.02156.x.
|
| 428 |
Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.Mol Cell Biol. 2007 Sep;27(17):6068-83. doi: 10.1128/MCB.00664-07. Epub 2007 Jun 25.
|
| 429 |
Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.Oncol Res. 2017 Aug 7;25(7):1061-1068. doi: 10.3727/096504016X14830466773541. Epub 2017 Jan 20.
|
| 430 |
No association of single nucleotide polymorphisms involved in GHRL and GHSR with cancer risk: a meta-analysis.Cancer Biomark. 2015;15(1):89-97. doi: 10.3233/CBM-140441.
|
| 431 |
Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.World J Gastroenterol. 2006 Nov 28;12(44):7104-12. doi: 10.3748/wjg.v12.i44.7104.
|
|
|
|
|
|
|
